Acalabrutinib from ABBEXA LTD

Search, find, compare suppliers for Acalabrutinib products.

Edit 
Product NameAcalabrutinib
DescriptionAcalabrutinib is a small molecule which can act as a Highly selective BTK inhibitor. It is provided as a powder.

This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Proliferation, Cytokine.
This product may be of interest in the following research areas and diseases: Immunology, Cancer, Inflammation.
This product may act as a Coronavirus inhibitor: Limits ?cytokine storm? in humans.

Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 465.52 g/mol
Size5 mg, 25 mg
Concentrationn/a
Applicationsn/a
Other NamesAcalabrutinib, 4-[8-Amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide, ACP-196, 1420477-60-6
Gene, Accession, CAS #CAS: 1420477-60-6
Catalog #abx283112
Priceplease inquire
Order / More InfoAcalabrutinib from ABBEXA LTD
Product Specific Referencesn/a
ABBEXA LTD
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950

Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com

https://www.abbexa.com

U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413

Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950


Profile of ABBEXA LTD

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.